Daily Stock Analysis, CHFS, CHF Solutions Inc, priceseries

CHF Solutions Inc. Daily Stock Analysis
Stock Information
Open
2.12
Close
2.13
High
2.21
Low
2.06
Previous Close
2.12
Daily Price Gain
0.01
YTD High
13.90
YTD High Date
Jan 15, 2019
YTD Low
2.05
YTD Low Date
Sep 16, 2019
YTD Price Change
-5.15
YTD Gain
-70.74%
52 Week High
18.90
52 Week High Date
Nov 6, 2018
52 Week Low
2.05
52 Week Low Date
Sep 16, 2019
52 Week Price Change
-14.67
52 Week Gain
-87.32%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 29. 2017
302.40
Jun 30. 2017
379.40
1 Trading Days
25.46%
Link
LONG
Jul 13. 2017
229.60
Jul 14. 2017
245.69
1 Trading Days
7.01%
Link
LONG
Nov 15. 2017
231.00
Nov 16. 2017
283.50
1 Trading Days
22.73%
Link
LONG
Jan 26. 2018
57.12
Jan 29. 2018
62.16
1 Trading Days
8.82%
Link
LONG
Mar 2. 2018
44.66
Mar 20. 2018
51.54
12 Trading Days
15.41%
Link
LONG
Jan 11. 2019
8.65
Jan 17. 2019
9.28
4 Trading Days
7.31%
Link
LONG
Feb 14. 2019
9.45
Feb 21. 2019
10.09
4 Trading Days
6.75%
Link
LONG
Jun 12. 2019
3.16
Jun 13. 2019
3.33
1 Trading Days
5.38%
Link
Company Information
Stock Symbol
CHFS
Exchange
NasdaqCM
Company URL
http://www.sunshineheart.com
Company Phone
952-345-4200
CEO
John L. Erb
Headquarters
Minnesota
Business Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE, MN 55344
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001506492
About

Sunshine Heart, Inc. is an early-stage medical device company, which provides products for the treatment of fluid overload. It engages in the development, manufacture, and commercialization of Aquadex FlexFlow System, which provides an ultrafiltration treatment for patients with failed diuretic therapy and require hospitalization. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Description

Sunshine Heart, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Sunshine Heart, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.